Lorise C Gahring

Title: Lorise C Gahring: Innovator in Neurotransmitter Research

Introduction

Lorise C Gahring is a prominent inventor based in Salt Lake City, UT (US). She has made significant contributions to the field of neuroscience, particularly in the study of autoantibodies and their implications in various neurodegenerative diseases. With a total of 2 patents, her work is paving the way for new treatment methodologies.

Latest Patents

Gahring's latest patents focus on innovative peptides that target autoantibodies associated with neurological disorders. One of her notable inventions is a peptide containing 24 amino acid residues that binds to anti-neuronal-glutamate-receptor autoantibodies linked to Rasmussen's encephalitis. This peptide not only blocks the activation of the GluR3 subunit but also provides methods for treating the condition. Additionally, her research addresses autoantibodies related to other glutamate receptor subunits, which are implicated in paraneoplastic neurodegenerative diseases, amyotrophic lateral sclerosis, and other neurodegenerative disorders of unknown diagnosis. Methods for screening and monitoring patients undergoing treatment for these conditions are also detailed in her patents.

Career Highlights

Lorise C Gahring is affiliated with the University of Utah Research Foundation, where she continues her groundbreaking research. Her work has garnered attention for its potential to improve patient outcomes in neurodegenerative diseases.

Collaborations

Gahring collaborates with esteemed colleagues such as Scott W Rogers and Roy E Twyman, contributing to a rich environment of innovation and research.

Conclusion

Lorise C Gahring's contributions to neuroscience through her patents and research are invaluable. Her innovative approaches to understanding and treating neurological disorders highlight her role as a leading inventor in the field.